Tell us what's wrong and we'll take a look.
Thanks – we got it. We'll review and follow up if needed.
Dr. Cobbina, able to think at the speed of light and instantly diagnose any situation, heads an enigmatic corporation known only as OMNI, giving her the resources she needs to search for others like her. She's on a quest to learn the origin of her new powers--but, along the way, discovers that the fate of the entire world may rest on her shoulders!
Collects Omni #5-10
Currently story editor on the 22nd season of NBCUniversal's Law & Order: SVU, Melody was previously staff writer on the second season of Two Sentence Horror Stories, currently airing on Netflix (episodes "Quota" and "Ibeji"). Melody is currently developing a sci fi horror TV pilot in the Sundance Episodic Lab's new Idea Lab, and has been named one of the Top 25 Screenwriters to Watch in 2021 by the International Screenwriters Association. She was a 2019 HBO Access Writing Fellow and a winner of a Grand Jury Prize for Best Screenplay at the Urbanworld Film Festival. Melody has been a Fellow at several labs, including Shudder Labs, Stowe Story Labs (winner of the Tangerine Entertainment Fellowship) and NY Stage & Film. Also an award-winning playwright, Melody received a Ford Foundation grant to travel to Rwanda to develop her play Sweet Mercy, which was later developed by NY Stage and Film, starring Danai Gurira. Her play Day of Reckoning, about Lucy Parsons and the early Labor Movement in America, was produced in NY and won the Jane Chambers Award. Melody writes the comic book OMNI about a young Black woman doctor with super intelligence (Vol. 2: Issues #5 - 10) published by Mark Waid at Humanoids. She co-founded the group of women horror writers and filmmakers called NYX Horror Collective, and is developing an original horror feature with Fear Works that she will direct in Canada.
Readwise Books is an ebook & audiobook platform that automatically logs how much you and your friends read, making it fun and easy to read more. Learn more →
Enter your email to continue. We'll create your account if you're new here.